BioRestorative Therapies Inc (BRTX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8090
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. The company operates in the US. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc (BRTX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12
BioRestorative Therapies Enters into Research Agreement with Pfizer 13
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14
BioRestorative Therapies Enters into Agreement with Japanese pharma 15
BioRestorative Therapies Enters Into Research Agreement With University of Utah 16
Licensing Agreements 17
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17
Equity Offering 18
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 21
Debt Offering 22
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24
BioRestorative Therapies Inc – Key Competitors 25
BioRestorative Therapies Inc – Key Employees 26
BioRestorative Therapies Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Corporate Communications 28
Jul 25, 2018: BioRestorative Therapies Appoints Jason M. Lipetz to its Scientific Advisory Board 28
Jan 22, 2018: BioRestorative Therapies Appoints Adam D. Bergstein as Senior Vice President, Planning and Business Development 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12
BioRestorative Therapies Enters into Research Agreement with Pfizer 13
BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14
BioRestorative Therapies Enters into Agreement with Japanese pharma 15
BioRestorative Therapies Enters Into Research Agreement With University of Utah 16
BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17
BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18
BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19
BioRestorative Therapies Completes Private Placement Of Shares For US$0.5 Million 21
BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22
BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23
BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24
BioRestorative Therapies Inc, Key Competitors 25
BioRestorative Therapies Inc, Key Employees 26
BioRestorative Therapies Inc, Subsidiaries 27

List of Figures
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioRestorative Therapies Inc (BRTX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Providence Resources plc (PZQA):企業の財務・戦略的SWOT分析
    Summary Providence Resources Plc (Providence Resource) is an upstream oil and gas exploration and development company that explores and develops hydrocarbon assets. The company's areas of operations include Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's basin an …
  • Manitou BF SA:企業の戦略・SWOT・財務情報
    Manitou BF SA - Strategy, SWOT and Corporate Finance Report Summary Manitou BF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tennessee Valley Authority:企業の戦略的SWOT分析
    Tennessee Valley Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • JBS S.A.:企業のM&A・事業提携・投資動向
    JBS S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JBS S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Grupo Aeroportuario del Sureste SAB de CV:企業の戦略・SWOT・財務情報
    Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Sureste SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Cybernet Systems Corporation:企業の戦略・SWOT・財務情報
    Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ISA Pharmaceuticals BV:製薬・医療:M&Aディール及び事業提携情報
    Summary ISA Pharmaceuticals BV (ISA Pharmaceuticals) is a developer of synthetic therapeutic vaccines for the treatment of cancer and persistent viral infections. The company’s pipeline products include ISA101, an immunotherapeutic vaccine for cervical cancer; MyISA, a personalized immunotherapy bas …
  • Spotless Group Holdings Ltd:企業の戦略・SWOT・財務分析
    Spotless Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Spotless Group Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Empire Resorts Inc:戦略・SWOT・企業財務分析
    Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Empire Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nippon Yusen Kabushiki Kaisha (9101):石油・ガス:M&Aディール及び事業提携情報
    Summary Nippon Yusen Kabushiki Kaisha (NYK) is a logistics company. It transports crude oil and allied products. The company provides ocean, land, and air transport services for the transportation of petroleum products, liquid products and dry bulk products. Its portfolio includes linear trade, air …
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …
  • NHPC Ltd (NHPC):企業の財務・戦略的SWOT分析
    NHPC Ltd (NHPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Shinkin Central Bank:企業の戦略・SWOT・財務情報
    Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report Summary Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Constantia Industries AG:企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Emisphere Technologies Inc (EMIS)-製薬・医療分野:企業M&A・提携分析
    Summary Emisphere Technologies Inc (Emisphere) is a specialty pharmaceutical and drug delivery company. The company in partnership with global pharmaceutical companies develops novel oral formulations of existing injectable bio-pharmaceutical products, besides new chemical entities, using its Eligen …
  • GenMark Diagnostics Inc (GNMK):医療機器:M&Aディール及び事業提携情報
    Summary GenMark Diagnostics Inc (GenMark) is a medical device company that provides clinical testing systems. The company provides products such as XT-8 systems and ePlex systems. It offers pipeline products such as eSensor 2C 19 genotyping test, eSensor HCV genotyping test, eSensor HCVg direct test …
  • Plug Power Inc (PLUG):企業の財務・戦略的SWOT分析
    Summary Plug Power Inc (Plug Power) is an alternative energy company that designs and develops fuel cell structures. The company’s products comprise gendrive, genkey, material handling products, gensure, genfuel and genfuel for stationary markets products. Its material handling products comprise out …
  • Strand Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequenc …
  • Florida Hospital:製薬・医療:M&Aディール及び事業提携情報
    Summary Florida Hospital is a healthcare service provider. The hospital offers clinical services and treatments in the areas of bariatric, behavioral health, cancer, cardiovascular, diabetes, emergency services, gastrointestinal, general surgery, gynecology, hepatology, imaging, laboratory services, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆